OCT 03, 2018 12:00 PM PDT

Using CRISPR and Stem Cells to Treat Genetic Disease

Presented at: CRISPR 2018
Speaker
  • Senior Investigator, Gladstone Institute of Cardiovascular Disease, Professor Department of Medicine, Division of Genomic Medicine, University of California, San Francisco
    Biography
      Bruce R. Conklin is an Investigator at the Gladstone Institutes and a Professor at UCSF in the departments of Medicine, Ophthalmology and Pharmacology. Conklin is also the Deputy Director of the Innovative Genomics Institute. His research focuses on biomedical applications of CRISPR technology with an emphasis on allele-specific editing of dominant negative disease genes in the retina, motor neurons and cardiac tissue. Conklin uses patient-specific iPSC-derived tissues for pre-clinical genome surgery studies. Conklin began research training with Julius Axelrod, Ph.D., (Nobel Laureate, NIH), did his residency at Johns Hopkins and a postdoctoral fellowship with Henry Bourne (UCSF). In 1995 Conklin joined the Gladstone Institutes and UCSF as faculty. Conklin is the founder of several public stem cell and genomics projects including BayGenomics, GenMAPP and WikiPathways. He pioneered the use of designer G protein coupled receptors (RASSLs) for tissue engineering. He is the Gladstone Scientific Officer for Technology & Innovation. He serves on multiple scientific advisory boards including the Allen Institute for Cell Science, Chinese University of Hong Kong, Tenaya Therapeutics and the Exploratorium. He is a member of the American Society for Clinical Investigation, and is a Fellow in the California Academy of Sciences.

    Abstract

    Decoding human genetic disease allows us to develop models of the pathology that can be directly tested with gene correction or targeted drug therapy.  Dominant negative mutations are particularly promising therapeutic targets since they are resistant to traditional therapies, yet precise excision of disease-causing allele could provide a cure. We are using patient-derived induced pluripotent stem cells (iPSCs) to model diseases in tissues that are particularly susceptible to dominant negative mutations: cardiomyocytes, motor neurons and retinal pigment epithelial (RPE) cells. By developing CRISPR genome surgery in human cells, we hope to devise improved cellular models as well as human therapies.  By focusing on allele-specific gene excision we can select gene mutations that are highly penetrant, with clear phenotypes in cell types that can be readily derived from iPSCs.  We use whole genome sequencing to identify common genetic polymorphisms that can be used to selectively inactivate the disease allele with CRISPR nucleases.  The diseased cell types allow us to decode the cellular signatures of disease and determine if the excision of the disease allele restores cellular functioning.  Genome surgery is a rapidly advancing field that uses state-of-the-art techniques that pushes the boundaries of cell and molecular biology. We use advanced microscopy, tissue engineering and single cell genomics to optimize precise editing. We are developing computational methods to select optimal CRISPR/Cas9 combinations in diverse populations. We aim to produce therapies that are safe and cost effective so that they can benefit the maximal number of people. In collaboration with clinical scientists and the Innovative Genomics Institute (https://innovativegenomics.org/) we are preparing large animal models and clinical grade reagents to prepare for human clinical trials.  

    Learning Objectives: 

    1. Specific examples of where genome surgery could be used
    2. Future directions in genome surgery


    Show Resources
    You May Also Like
    MAY 11, 2021 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    MAY 11, 2021 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
    NOV 16, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    JUN 09, 2021 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    JUN 09, 2021 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
    DEC 02, 2020 8:00 AM PST
    C.E. CREDITS
    DEC 02, 2020 8:00 AM PST
    DATE: December 2nd, 2020 TIME: 08:00am PDT, 11:00pm EDT Bioreactors and shakers are used to cultivate microorganisms, plant, insect, and mammalian cells in different volumes. Upscaling of pr...
    FEB 24, 2021 10:00 AM PST
    C.E. CREDITS
    FEB 24, 2021 10:00 AM PST
    DATE: February 24, 2021 TIME: 10am PST Automated lab instruments such as liquid handlers and cell sorters are increasingly common in all types of laboratories, driving fast results for labor...
    OCT 03, 2018 12:00 PM PDT

    Using CRISPR and Stem Cells to Treat Genetic Disease

    Presented at: CRISPR 2018

    Specialty

    Gene Sequencing

    Dna Sequencing

    Clinical Diagnostics

    Gene Expression

    Dna

    Crispr-Cas9

    Cell Culture

    Immunology

    Pcr/rt-Pcr/real-Time Pcr

    Oncology

    Immuno-Oncology

    Cancer Diagnostics

    T-Cells

    Genetics

    Antibodies

    Geography

    North America30%

    Europe30%

    Asia20%

    Registration Source

    Website Visitors100%

    Job Title

    Research Scientist38%

    Student13%

    Educator/Faculty13%

    Medical Laboratory Technician13%

    Genetic Counselor13%

    Lab Management13%

    Organization

    Academic Institution30%

    Diagnostic Company10%

    Government/public10%

    Manufacturer - Other10%

    Research Institute10%

    Clinical Laboratory10%


    Show Resources
    Loading Comments...
    Show Resources
    Attendees
    • See more